Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Article Information — French Guiana

All Issues

<< Return to Articles by Country Search

Click column headers to sort.
Title Volume Issue Article Type Year Month
Resistance to Dihydroartemisinin 13 5 Letter 2007 5
Saksenaea vasiformis Infection, French Guiana 14 2 Letter 2008 2
Echinococcus vogeli Infection in a Hunter, French Guiana 15 12 Dispatch 2009 12
Concurrent Dengue and Malaria in Cayenne Hospital, French Guiana 15 4 Dispatch 2009 4
Hantavirus Pulmonary Syndrome, French Guiana 16 4 Letter 2010 4
Quinine-Resistant Malaria in Traveler Returning from French Guiana, 2010 17 5 Letter 2011 5
Plasmodium vivax Malaria among Military Personnel, French Guiana, 1998–2008 17 7 Dispatch 2011 7
Reemergence of Dengue Virus Type 4, French Antilles and French Guiana, 2004–2005 12 11 Dispatch 2006 11
Malaria Outbreak in Troops Returning from French Guiana 12 11 Letter 2006 11
New World Hantavirus in Humans, French Guiana 12 8 Letter 2006 8
Leishmaniasis among Gold Miners, French Guiana 12 7 Letter 2006 7
Unique Clone of Coxiella burnetii Causing Severe Q Fever, French Guiana 19 7 Dispatch 2013 7
Streptococcus suis Meningitis and Bacteremia in Man, French Guiana 19 9 Letter 2013 9
Genome Analysis of Mayaro Virus Imported to Germany from French Guiana 20 7 Letter 2014 7
Three-Toed Sloth as Putative Reservoir of Coxiella burnetii, Cayenne, French Guiana 20 10 Letter 2014 10
Outbreak of Leishmania braziliensis Cutaneous Leishmaniasis, Saül, French Guiana 21 5 Letter 2015 5
Malaria in French Guiana Linked to Illegal Gold Mining 22 2 Letter 2016 2
Malaria Hyperendemicity and Risk for Artemisinin Resistance among Illegal Gold Miners, French Guiana 22 5 Dispatch 2016 5
Maguari Virus Associated with Human Disease 23 8 Research 2017 8
Hantavirus Pulmonary Syndrome Caused by Maripa Virus in French Guiana, 2008–2016 23 10 Dispatch 2017 10
Epidemic Cholera in the New World: Translating Field Epidemiology into New Prevention Strategies 1 4 Dispatch 1995 10
Q Fever in French Guiana: New Trends 4 1 Letter 1998 3
First Case of Yellow Fever in French Guiana since 1902 5 3 Dispatch 1999 6
Zika Virus Persistence and Higher Viral Loads in Cutaneous Capillaries Than in Venous Blood 23 11 Research Letter 2017 11
Mayaro Virus in Wild Mammals, French Guiana 9 10 Dispatch 2003 10
Severe Acquired Toxoplasmosis Caused by Wild Cycle of Toxoplasma gondii, French Guiana 15 4 Dispatch 2009 4
Dengue Spatial and Temporal Patterns, French Guiana, 2001 10 4 Research 2004 4
Antibacterial Resistance, Wayampis Amerindians, French Guyana 10 6 Dispatch 2004 6
Maripa Virus RNA Load and Antibody Response in Hantavirus Pulmonary Syndrome, French Guiana 24 9 Dispatch 2018 9
Q Fever Wildlife Reservoir 11 5 Letter 2005 5
Recurrent American Cutaneous Leishmaniasis 13 9 Letter 2007 9
Escherichia coli as Reservoir for Macrolide Resistance Genes 15 10 Dispatch 2009 10
Salmonella enterica Serotype Typhi with Nonclassical Quinolone Resistance Phenotype 17 6 Dispatch 2011 6
Performance of 2 Commercial Serologic Tests for Diagnosing Zika Virus Infection 25 6 Research 2019 6
Capybara and Brush Cutter Involvement in Q Fever Outbreak in Remote Area of Amazon Rain Forest, French Guiana, 2014 26 5 Dispatch 2020 5
Prolonged Maternal Zika Viremia as a Marker of Adverse Perinatal Outcomes 27 2 Research 2021 2
Venezuelan Equine Encephalitis Complex Alphavirus in Bats, French Guiana 27 4 Dispatch 2021 4
Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021 27 10 Dispatch 2021 10
Outbreak of Oropouche Virus in French Guiana 27 10 Dispatch 2021 10
Tonate Virus and Fetal Abnormalities, French Guiana, 2019 28 2 Dispatch 2022 2
Novel Chronic Anaplasmosis in Splenectomized Patient, Amazon Rainforest 28 8 Dispatch 2022 8
Novel Species of Brucella Causing Human Brucellosis, French Guiana 29 2 Research 2023 2

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external